But what is really behind this medical phenomenon? Why has this drug – whose active ingredient is semaglutide – become a true revolution in the treatment of obesity and type 2 diabetes?
He Dr. Leonardo Sandea renowned specialist in internal medicine and obesity, explains it clearly: “Semaglutide acts on several mechanisms in the body, helping to control appetite and improving metabolism. It works directly on the brain centers that regulate hunger and satiety.”
In other words, the medication reduces appetite, improves blood sugar control and prolongs the feeling of satiety, which makes it easier to maintain a balanced diet and achieve sustainable weight loss. In addition, new studies show that it can have positive effects on the heart and other functions of the body, expanding its potential beyond the aesthetic field.
However, Dr. Sande insists that this is not a “magic cure”. “It is a great tool, but obesity continues to be a complex, multifactorial and progressive disease. No medication can replace changes in habits or psychological support that are an essential part of the treatment,” explains.
Semaglutide is administered once a week, and its use is indicated mainly in patients with obesity or type 2 diabetes, pathologies that often occur together. “The benefit is clear when we talk about people with excess weight and associated risk factors. But using it without medical need, only for aesthetic purposes, implies taking unnecessary risks,” the doctor warns.
Like any treatment, it may present side effects, most of them mild and temporary, such as nausea or constipation. “These are expected reactions and usually improve with adjustments in the dose,” clarifies Sande. Serious complications are extremely rare, and the main contraindications are limited to very specific cases, such as patients with a history of medullary thyroid cancer.
Beyond the media boom, specialists agree that these medications mark a before and after in medicine. Until recently, the leap between non-invasive treatment (diet, exercise) and bariatric surgery was enormous. Today, semaglutide represents an effective and safe intermediate option when used correctly.
The great challenge, concludes Dr. Sande, “It is not losing sight of the fact that obesity is a chronic disease that requires a comprehensive approach. Semaglutide may be the boost that many patients needed to begin their change, but true success lies in maintaining it over time, accompanied by a medical team and a healthy lifestyle.”
In a context where obesity is growing worldwide, this drug not only promises physical improvement, but also a new opportunity to regain health. Because more than a fashionable drug, semaglutide is, today, one of the most hopeful tools of modern medicine.
For more information about Dr. Leonardo Sande, his clinic and his anti-obesity programs, you can visit his website www.clinicasande.com.uy call (+598) 98 275 020 or write to [email protected]. You can also follow Dr. Sande on Instagram @drleonardosande to stay up to date with the latest health and wellness news and advice.
by CONTENTNOTICAS
Image gallery
